[Anthracycline-induced cardiotoxicity: report of fatal cases].
暂无分享,去创建一个
R. Rivas-Ruíz | O. Castelán-Martínez | Yadira Betanzos-Cabrera | María de Jesús Estrada-Loza | R. Rivas-Ruiz | J. L. Vargas-Neri
[1] S. Sallan,et al. Managing Chemotherapy-Related Cardiotoxicity in Survivors of Childhood Cancers , 2014, Pediatric Drugs.
[2] C. Gale,et al. Cardiovascular sequelae in long-term survivors of young peoples' cancer: a linked cohort study , 2014, British Journal of Cancer.
[3] S. Lipshultz,et al. Treatment-related cardiotoxicity in survivors of childhood cancer , 2013, Nature Reviews Clinical Oncology.
[4] A. S. Shaikh,et al. Anthracycline-induced cardiotoxicity: prospective cohort study from Pakistan , 2013, BMJ Open.
[5] S. Raman,et al. Occult Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy , 2013, Circulation. Cardiovascular imaging.
[6] T. Marwick,et al. Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis. , 2013, European journal of cancer.
[7] W. Hundley,et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. , 2013, JACC. Cardiovascular imaging.
[8] S. Meikle,et al. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy. , 2013, European heart journal cardiovascular Imaging.
[9] S. Lipshultz,et al. Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer , 2011, Pediatric Cardiology.
[10] C. Lim,et al. Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? , 2010, Progress in cardiovascular diseases.
[11] J. Bourhis,et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J. Bryant,et al. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. , 2007, Health technology assessment.
[13] S. Lipshultz,et al. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management , 2007, Expert opinion on pharmacotherapy.
[14] P. Voûte,et al. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] D. Keefe,et al. Anthracycline-induced cardiomyopathy. , 2001, Seminars in oncology.
[16] M. Green,et al. New anthracycline antitumor antibiotics. , 1991, Critical reviews in oncology/hematology.
[17] J. Plana. Update : Systemic Diseases and the Cardiovascular System ( IV ) Chemotherapy and the Heart , 2017 .
[18] G. Roul,et al. [Anthracycline-induced cardiomyopathy]. , 2009, Presse medicale.
[19] H. Dickinson,et al. Cardioprotective interventions for cancer patients receiving anthracyclines. , 2005, The Cochrane database of systematic reviews.
[20] S. Lipshultz,et al. Anthracycline-induced cardiotoxicity in children and young adults. , 1998, Critical reviews in oncology/hematology.